Board Chairman & Investor @ CardiaCare | Partner @ MedTech Advantage Fund | Digital Health & MedTech Startup Board Member, Investor & Mentor @ HeartBeam, BloomLife, & HeartX
“Cardiology continues to have the second largest number of clinical artificial intelligence (AI) algorithms cleared by the U.S. Food and Drug Administration, trailing only radiology. The FDA's latest update covers all AI approvals through May 2024. There are now 122 FDA-cleared AI algorithms specific to cardiology. This makes up 14% of the 882 clinical AI algorithms now on the U.S. market. The new FDA numbers include market clearances up to March 31, 2024. The first approval of a clinical AI algorithm was in 1995. The first cardiology specific algorithm was for HeartFlow FFR-CT in 2016. That algorithm was also the first AI to be included in a cardiology guideline when the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain was released.” MedTech Innovator American Heart Association #epeeps Heart Rhythm Society American College of Cardiology LSI Capital Factory Company Ventures MedTech Strategist Health Wildcatters Techstars